HIV Education Kit for Adolescents (Pencegahan HIV di Kalangan Remaja), PREM-Kit

Universiti Teknologi Mara

Status: Completed

Conditions: Human Immunodeficiency Virus

Treatments: Other: PREM-Kit

Study type: Interventional

Funder types: Other

Identifiers

NCT05623800

REC/05/2022 (ST/MR/85)

Details and patient eligibility

About

The goal of this community trial is to provide HIV education based on the newly developed HIV education kit (PREM-Kit) and evaluate the knowledge, attitude and practices related to HIV prevention among the late adolescents (aged 18 to 19 years old) in Malaysia. The main question it aims to answer is does the PREM-Kit improve the knowledge, attitude and practices related to HIV prevention among the adolescent?

Participants will be asked to:

• answer a questionnaire as a baseline screening to determine their knowledge, attitude and practices related to HIV prevention.
• Using PREM-Kit, they will participate in a series of health education sessions. There will be three sessions in total which will be delivered two weekly apart. Each of the sessions will take approximately 20 minutes duration.
• Following the last session (third session), participants will have to answer the same questionnaire ; once immediately after the last session, once at 3-months post-intervention, and lastly, at 4-months post-intervention.

Researchers will compare participants who received the existing Basic Science and Biology module to see if there is any improvement in the knowledge, attitude and practices related to HIV prevention.

Enrollment: 189 patients

Sex: All

Ages: 18 to 19 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• late adolescents aged 18 - 19 years
• student who attends Health Science Diploma course in the year 2023
• Malaysian citizen

Exclusion criteria

• student who refused to participate in the study
• student who is absent on the first session of the intervention
• student who does not understand the Malay language

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

189 participants in 2 patient groups

PREM-Kit group

Experimental group

Treatment:

Other: PREM-Kit

Control group

No Intervention group